Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2024-06-27 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2024-06-27 English
6-K
Foreign Filer Report
2024-06-24 English
Transaction in Own Shares 2024
Transaction in Own Shares Classification · 1% confidence The document text consists almost entirely of tables detailing transactions involving 'Genmab A/S' with columns for Date, Time, Price, Quantity, and Venue (e.g., XCSE, CEUX). This structure is characteristic of regulatory filings reporting insider transactions or significant shareholding changes. Since the data explicitly shows transactions (Price and Quantity) by an issuer (Genmab A/S) on specific dates, it strongly suggests a report of personal share transactions by directors/executives (Director's Dealing - DIRS) or a notification of changes in significant share ownership (Major Shareholding Notification - MRQ). Given the granular, time-stamped nature of the trades, it aligns best with insider trading reports or transaction notifications. Comparing DIRS (personal share transactions by directors) and MRQ (notification of changes in significant share ownership), this data looks like a direct report of transactions. However, without explicit context stating these are director trades, the most general category for transaction reporting that isn't a buyback (POS) or capital change (SHA) is often related to insider activity or major holdings. Since the data is a raw log of trades, and it is not explicitly stated to be a director's dealing, it could also fall under a general regulatory filing (RNS) or a major shareholding notification (MRQ) if the quantities cross a threshold. Given the context of financial reporting databases, detailed transaction logs like this often relate to insider reporting (DIRS) or major holding changes (MRQ). Since the document is very long (2.3M chars) and contains detailed transaction data, it is the report itself, not an announcement of a report (ruling 2 does not apply). Based on the content being a log of share transactions, DIRS (Director's Dealing) is a strong candidate, but MRQ (Major Shareholding Notification) is also plausible if the trades aggregate to a threshold. Lacking explicit headers, I will classify this as a report of insider transactions, which maps closely to DIRS, or a general regulatory filing (RNS) if it's a mandatory exchange notification. Given the format is a detailed transaction log, DIRS is the most specific fit for reporting individual trades. If it were a formal SEC/equivalent filing header, it would be clearer. In the absence of clear headers, and seeing detailed trade logs, DIRS or MRQ are the best fits. I will lean towards DIRS as it captures the essence of reporting share transactions.
2024-06-24 English
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 1% confidence The document is a formal company announcement from Genmab detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, average prices, and total values, and explicitly states the number of treasury shares held following these transactions. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2024-06-24 English
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 1% confidence The document is a formal company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily trading activity, total shares repurchased, and the impact on treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buy-back reports. While it mentions attachments, the text itself contains the primary data regarding the buy-back, distinguishing it from a mere publication announcement.
2024-06-24 Danish
6-K
Foreign Filer Report
2024-06-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.